Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 1

2(25.0%)

Phase 2

1(12.5%)

8Total

N/A(5)

Phase 1(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT00549354Phase 2Unknown

Abdominal Aortic/Aorto-Iliac Aneurysm Endoluminal Graft Study

Role: lead

NCT00546312Not ApplicableUnknown

Clinical Study of Thoracic Excluder Endoprosthesis to Treat Descending Thoracic Aortic Diseases

Role: lead

NCT00549380Phase 1Unknown

Clinical Study of Aneurysm Exclusion

Role: lead

NCT00549432Not ApplicableUnknown

Clinical Study of Abdominal Aortic Aneurysm Exclusion (TALENT Abdominal)

Role: lead

NCT00549315Not ApplicableUnknown

Clinical Study of Thoracic Aortic Aneurysm Exclusion

Role: lead

NCT00549016Not ApplicableUnknown

Clinical Study of Aneurysm Exclusion

Role: lead

NCT00902317Not ApplicableTerminated

Prime Time for Superficial Femoral Artery (SFA) - The SFA Study

Role: lead

NCT00271076Phase 1Completed

CAPITAL: Carotid Artery Plaque Intravascular Ultrasound Evaluation

Role: lead

All 8 trials loaded